Results 191 to 200 of about 7,663 (215)

Tocilizumab versus Rituximab in Patients with Moderate to Severe Steroid-resistant Graves’ Orbitopathy

Ocular Immunology and Inflammation, 2022
Vincent Borderie, Arsene Mekinian
exaly  

EMERGENCY TREATMENT OF GRAVES ORBITOPATHY

2011
GRAVES ORBITOPATHY EMERGENCY DEPARTMENT SUDDEN IMPAIRMENT ...
FINI, Giuseppina, E. Mici, C. M. Scannavino, LEONARDI, ALESSANDRA, Salvatore Monti, S. Amodeo, E. Fiesoletti, V. Pellacchia, CARINI, Luisa   +8 more
openaire   +2 more sources

Radiotherapy for Graves' orbitopathy: randomised placebo-controlled study

Lancet, The, 2000
Caroline B Terwee
exaly  

Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy

Lancet, The, 1999
Petros Perros
exaly  

Glucocorticoids in Graves’ orbitopathy: mechanisms of action and clinical application

Therapeutic Advances in Endocrinology and Metabolism, 2020
George J Kahaly
exaly  

New insights into the pathogenesis and nonsurgical management of Graves orbitopathy

Nature Reviews Endocrinology, 2019
Lei Zhang, Richard W J Lee, Ilaria Muller   +2 more
exaly  

Polydatin attenuates orbital oxidative stress in Graves’ orbitopathy through the NRF2 pathway

Chemico-Biological Interactions, 2020
Hong Li
exaly  

CTLA-4 and HLA gene susceptibility to thyroidassociated orbitopathy

Lancet, The, 1999
Raffaella Buzzetti, Lorenza Nisticò, Alberto Signore   +2 more
exaly  

Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study

Journal of Endocrinological Investigation, 2020
Petros Perros
exaly  

Graves’ Orbitopathy

2022
openaire   +1 more source